Aleris - Radiology acquired by Meine Radiologie
Context
The divestment of Aleris' radiology arm to Meine Radiologie Holding (backed by EQT Infrastructure) marks a significant consolidation in the Nordic diagnostic imaging market. This transaction was executed in tandem with the sale of Aleris' primary care and rehab units to Praktikertjänst, as part of a broader strategic shift. The rationale for Aleris, under Triton's ownership, is to exit non-core segments to focus exclusively on becoming a specialized healthcare provider in Scandinavia. For the acquirer, the deal provides a major entry point into the Norwegian and Swedish markets, significantly expanding its existing German-focused radiology platform. The integration of 36 diagnostic units allows for significant scale advantages in procurement, technological investment, and standardized medical reporting. This move is consistent with the trend of private equity-backed platforms seeking to create pan-European leaders in capital-intensive medical sub-sectors like radiology.
Aleris - Radiology, which reported an EBITDA margin of [members only] in 2023, is valued in this transaction at an EV/EBITDA multiple of 10x–18x, standing directly in line with the average observed in the Healthcare & Pharma sector (16.1x in 2022).
-> Deep-dive in Healthcare & Pharma market trends
Target
The radiology division of Aleris provides a comprehensive range of diagnostic imaging services through a network of 36 units across Scandinavia, specifically 14 locations in Norway and 22 in Sweden. The business model centers on performing over 1 million radiology exams annually, utilizing various modalities such as MRI, CT, and X-ray. It serves a diverse patient base, including those within the public healthcare system, insurance-covered individuals, and private-pay patients. By maintaining a large-scale regional footprint and specialized medical expertise, the division acts as a critical infrastructure partner for diagnostic services in the Nordic region. The operation is designed to deliver high-quality diagnostic accuracy and efficient patient throughput, supporting medical practitioners with essential imaging data for treatment planning and disease management.
Ent. Value
€300–700M
Equity Value
[members only]
Multiples
EV / Revenue
[members only]
EV / EBITDA
10x–18x
EV / EBIT
[members only]
Historical Financials (EUR)
Other operations with Meine Radiologie
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 07/2021 | EQT PARTNERS | MEINE RADIOLOGIE | GERMANY | Radiology |
Similar deals in Health Providers
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 06/2022 | EURAZEO | SEVETYS | FRANCE | Vet Clinics |
| 04/2022 | GROUPE BRUXELLES LAMBERT | AFFIDEA | NETHERLANDS | Radiology |
| 02/2022 | PARTNERS GROUP | FOREFRONT DERMATOLOGY | UNITED STATES | Outpatient Care |
| 01/2022 | WREN HOUSE | VOYAGE CARE | UNITED KINGDOM | Nursing Homes |
| 12/2021 | VIVALTO PARTNERS / IK PARTNERS / MACSF / ARKEA CAPITAL / BNP PARIBAS DEVELOPPEMENT | VIVALTO SANTÉ | FRANCE | Clinics / Hospitals |
| 12/2021 | RAMSAY HEALTH CARE | ELYSIUM HEALTHCARE | UNITED KINGDOM | Clinics / Hospitals |
| 11/2021 | CERBA HEALTHCARE | LABEXA | FRANCE | Labs (Biology) |
| 10/2021 | IVC EVIDENSIA | VETONE | FRANCE | Vet Clinics |
| 10/2021 | THE CRANEMERE GROUP | OUTPATIENT IMAGING AFFILIATES | UNITED STATES | Radiology |
| 10/2021 | ARES / BPIFRANCE | POINT VISION | FRANCE | Ophthalmology |
REFERENCES
Valuation range: EV €300–700M
EBITDA range: €10–30M
EV/EBITDA range: 10x - 18x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Aleris - Radiology by Meine Radiologie are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Target: aleris - radiology
FAQ
What transaction does this page cover?
How was the acquisition of Aleris - Radiology by Meine Radiologie valued, and what multiples were paid?
What was Aleris - Radiology’s EBITDA at the time of the deal?
How does the valuation of Aleris - Radiology compare to benchmarks in the Healthcare & Pharma sector?
What sources support the information on this transaction?
What is mynth?